Scott Simon Tykodi

NPI 1114002938ActiveIndividual· Internal Medicine, Medical Oncology· Seattle, WA

Internal Medicine, Medical Oncology in Seattle, Washington, trained at Washington University School of Medicine (class of 1997). Their prescriptions cost Medicare Part D more than their services did: $2,638,928 for 247 claims, against $23,265 paid for services in 2024. Aveo Pharmaceuticals, Inc. was the largest of 2 companies reporting payments in 2025, $352.73 in all, mostly food and beverage.

Overview

NPI	1114002938
Status	Active
Entity type	Individual
Sole proprietor	No
NPI issued	Oct 27, 2006
Last updated in NPPES	Feb 20, 2013

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Medical Oncology Primary	207RX0202X	MD00038553	WA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Medical Oncology (WA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	114
Services billed	336 across 15 procedure codes
Paid by Medicare	$23,265

Part D prescriptions in 2024

Prescriptions (claims)	247 · 290 30-day fills
Patients	45
Total drug cost	$2,638,928
Generic share	49% of claims

Medicare sources and data years

Education and affiliations

Medical school	Washington University School of Medicine
Graduation year	1997
Medicare specialty	Medical Oncology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth